Morgan Stanley »

Blueprint Medicines shares owned by Morgan Stanley

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $100M 1.1M 94.86
2023-09-30 $18M 367k 50.22
2023-06-30 $25M 390k 63.20
2022-12-31 $20M 466k 43.75
2022-06-30 $84M 1.7M 50.53
2022-03-31 $0 225k 0.00
2021-06-30 $0 535k 0.00
2020-12-31 $0 234k 0.00
2020-09-30 $0 67k 0.00
2020-06-30 $0 76k 0.00
2020-03-31 $4.4M 76k 58.48
2019-12-31 $9.1M 114k 80.12
2019-09-30 $3.4M 47k 73.44
2019-03-31 $3.0M 38k 80.01
2018-12-31 $13M 241k 53.91
2018-09-30 $9.1M 117k 78.06
2018-06-30 $24M 373k 63.48
2018-03-31 $17M 187k 91.70
2017-12-31 $26M 344k 75.41
2017-03-31 $4.4M 110k 39.99
2016-12-31 $2.7M 95k 28.06
2016-09-30 $347k 9.4k 37.04
2016-06-30 $635k 31k 20.25
2016-03-31 $521k 29k 18.05
2015-12-31 $809k 31k 26.35
2015-09-30 $587k 28k 21.34
2015-06-30 $38k 1.4k 26.67